Advanced Biomed (ADVB) Total Current Liabilities (2024 - 2026)

Advanced Biomed has reported Total Current Liabilities for 3 years, with the latest figure at $1.4 million in Q1 2026.

• Quarterly Total Current Liabilities fell 65.34% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 65.34% YoY) and the FY2025 annual result came in at $10.1 million, up 269.43% from the prior year.
• Total Current Liabilities improved to $1.4 million in Q1 2026 per ADVB's latest filing, from $1.3 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $10.1 million in Q2 2025 and troughed at $1.3 million in Q4 2025.
• A 3-year average of $3.8 million and a median of $3.0 million in 2025 frame the typical range for Total Current Liabilities.
• The widest YoY moves for Total Current Liabilities: up 269.43% in 2025, down 67.26% in 2025.
• Over 3 years, Total Current Liabilities stood at $3.8 million in 2024, then slumped by 67.26% to $1.3 million in 2025, then rose by 13.73% to $1.4 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $1.4 million, $1.3 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.